重组性人参与氨基酸并列重复的表达,特征和抗结肠癌活性

Yu Feng1, Weina Li1, Weigang Yuwen2

  • 1Engineering Research Center of Western Resource Innovation Medicine Green Manufacturing, Ministry of Education, School of Chemical Engineering, Northwest University, Xi'an, 710069, China; Shaanxi R&D Center of Biomaterials and Fermentation Engineering, School of Chemical Engineering, Northwest University, Xi'an, 710069, China; Biotech. & Biomed. Research Institute, Northwest University, Xi'an, 710069, China.

概括

重组性人参,AT0601和AT0605的表达成功. AT0605对结肠癌细胞的抗癌活性明显高于AT0601,提供了一个更强大的治疗候选者.